Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482261
Status:
UNKNOWN
Last Update Posted:
2013-01-10
First Post:
2007-06-03
Brief Title:
A Study of Low Dose Lenalidomide and Dexamethasone in RelapsedRefractory Myeloma in Patients at High Risk for Myelosuppression
Sponsor:
Peter MacCallum Cancer Centre Australia
Organization:
Peter MacCallum Cancer Centre Australia
Organization Data
Organization:
Peter MacCallum Cancer Centre Australia
Class:
OTHER
Study ID:
RV-PI-0103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peter MacCallum Cancer Centre Australia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |